EFDID: 355833EFD: View Filing

Issuer: Akers Biosciences, Inc. (0001321834) - D

Accession: 0001493152-20-022415 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001321834
  • Entity Name:
    Akers Biosciences, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    NEW JERSEY
  • Year of Inc:
    Over 5 years ago
  • Address:
    201 GROVE ROAD
    THOROFARE, NJ 08086
  • Persons:
    Related Persons 5
    Stuart Benson
    Executive Officer 
    Chief Financial Officer
    Christopher C. Schreiber
    Executive Officer, Director 
    President and Chief Executive Officer
    Joshua Silverman
    Director 
    Chairman of the Board of Directors
    Bill J. White
    Director
    Robert C. Schroeder
    Director
EDGAR: Offering Information
  • Accession Date:
    11/24/2020
  • First Sale Date:
    11/11/2020
  • Offering Amount:
    $18,067,000
  • Amount Sold:
    $18,067,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    Represents 9,765,933 shares of common stock or pre-funded warrants and warrants to purchase 9,765,933 shares of common stock at $2.06 per share.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:IA, IN, MI, NJ
Inactive:IL
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Katalyst Securities LLC 112494 None None CA, CT, FL, GA, IL, IN, IA, MD, MA, MI, NJ, NY, OH, PA, SD
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Akers Biosciences, Inc./s/ Stuart BensonStuart BensonChief Financial Officer2020-11-24